Search results for: NICE
Filter search results
Cost-Effectiveness Thresholds: Economic and ethical issues
1 November 2002
…specific question: ‘Ought NICE to have a threshold incremental cost-effectiveness ratio (ICER)?’ -with an implicit second question ‘Should the threshold be explicit?’ Since its inception, NICE (the National Institute for…
Obstructive Sleep Apnoea: Health Economics Report
1 September 2014
…costs of OSA as well. Treatment for OSA varies with disease severity. In 2008, NICE assessed three interventions and recommended the use of CPAP machines for adults with moderate or…
Extrapolation from Progression-Free Survival to Overall Survival in Oncology
1 December 2016
…a regulatory agency (EMA) a “payer” organisation (NICE), academics, and from the member… This Research Paper reports on a literature review of trials using PFS as a surrogate for OS…
Establishing a Reasonable Price for an Orphan Drug
1 July 2018
…non-orphans, as the average non-orphan patient populations were around 80 and 100 patients per 50,000 people for SMC and NICE appraised drugs respectively, which are higher than the cut-off population…
Ethical and Economic Issues in the Appraisal of Medicines for Ultra-Rare Conditions
1 January 2020
In light of concerns that not all medicines for ultra-rare (also known as ultra-orphan) conditions are appraised under the same NICE process, a new OHE Consulting Report discusses the distinct…
Grace Hampson
28 May 2014
…and devices, and the economics of environmental sustainability in healthcare and life sciences. Grace previously worked developing NICE guidelines and has served as an advisor in economics across NICE’s Clinical…
The World Needs New Antibiotics. A Proposed US Program to Develop Them Offers a High Pay-Off
16 November 2022
…economics of antimicrobial resistance: Part 1: Why NICE and NHS England are Testing an Innovative HTA and Payment Model to Tackle AMR Part 2: Value Assessment within the NICE-NHS AMR…
G7 Investments in New Antibiotics Would Pay Off – For Everyone
9 December 2022
…for Global Development | Ideas to Action (cgdev.org) Related research OHE four-part blog series: The Economics of Antibiotics discussed the economics of antimicrobial resistance: Part 1: Why NICE and NHS…
Mike Drummond
3 February 2023
…Care Excellence (NICE) in the UK. He is currently Co-Editor-in-Chief of Value in Health and has been awarded 3 honorary doctorates, from City University (London), Erasmus University (Rotterdam) and the…